HK1208028A1 - Novel acetamide derivatives as trp channel antagonists - Google Patents
Novel acetamide derivatives as trp channel antagonists Download PDFInfo
- Publication number
- HK1208028A1 HK1208028A1 HK15108707.0A HK15108707A HK1208028A1 HK 1208028 A1 HK1208028 A1 HK 1208028A1 HK 15108707 A HK15108707 A HK 15108707A HK 1208028 A1 HK1208028 A1 HK 1208028A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- trifluoromethyl
- phenyl
- fluoro
- amino
- benzenesulfonyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261726154P | 2012-11-14 | 2012-11-14 | |
| US61/726,154 | 2012-11-14 | ||
| PCT/EP2013/073521 WO2014076038A1 (fr) | 2012-11-14 | 2013-11-11 | Nouveaux dérivés d'acétamide en tant qu'antagonistes des canaux trp |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1208028A1 true HK1208028A1 (en) | 2016-02-19 |
Family
ID=49553727
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15108707.0A HK1208028A1 (en) | 2012-11-14 | 2013-11-11 | Novel acetamide derivatives as trp channel antagonists |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9359337B2 (fr) |
| EP (1) | EP2920158A1 (fr) |
| JP (1) | JP2016503417A (fr) |
| KR (1) | KR20150082588A (fr) |
| CN (1) | CN104812740A (fr) |
| BR (1) | BR112015010687A2 (fr) |
| CA (1) | CA2889042A1 (fr) |
| HK (1) | HK1208028A1 (fr) |
| MX (1) | MX2015005711A (fr) |
| RU (1) | RU2015120214A (fr) |
| WO (1) | WO2014076038A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104203236A (zh) | 2012-01-17 | 2014-12-10 | 味之素株式会社 | 杂环酰胺衍生物和含有其的药物 |
| JP6975515B2 (ja) * | 2016-07-20 | 2021-12-01 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | Trpa1モデュレーターとしてのスルホニルシクロアルキルカルボキサミド化合物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002537293A (ja) * | 1999-02-20 | 2002-11-05 | アストラゼネカ アクチボラグ | カテプシンlおよび/またはカテプシンsの阻害剤としてのアセタミドアセトニトリル誘導体 |
| CA2706903C (fr) * | 2007-12-05 | 2015-11-17 | Henricus Jacobus Maria Gijsen | Agonistes de trpa1 dibenzoazepines et dibenzooxazepines |
| US8614201B2 (en) * | 2009-06-05 | 2013-12-24 | Janssen Pharmaceutica Nv | Heterocyclic amides as modulators of TRPA1 |
-
2013
- 2013-11-11 CN CN201380059012.5A patent/CN104812740A/zh active Pending
- 2013-11-11 EP EP13789018.2A patent/EP2920158A1/fr not_active Withdrawn
- 2013-11-11 WO PCT/EP2013/073521 patent/WO2014076038A1/fr not_active Ceased
- 2013-11-11 JP JP2015542231A patent/JP2016503417A/ja active Pending
- 2013-11-11 HK HK15108707.0A patent/HK1208028A1/xx unknown
- 2013-11-11 BR BR112015010687A patent/BR112015010687A2/pt not_active Application Discontinuation
- 2013-11-11 CA CA2889042A patent/CA2889042A1/fr not_active Abandoned
- 2013-11-11 KR KR1020157015240A patent/KR20150082588A/ko not_active Withdrawn
- 2013-11-11 RU RU2015120214A patent/RU2015120214A/ru not_active Application Discontinuation
- 2013-11-11 MX MX2015005711A patent/MX2015005711A/es unknown
-
2015
- 2015-05-14 US US14/712,655 patent/US9359337B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| RU2015120214A (ru) | 2017-01-10 |
| JP2016503417A (ja) | 2016-02-04 |
| US9359337B2 (en) | 2016-06-07 |
| US20150246906A1 (en) | 2015-09-03 |
| BR112015010687A2 (pt) | 2017-07-11 |
| WO2014076038A1 (fr) | 2014-05-22 |
| MX2015005711A (es) | 2015-08-20 |
| CN104812740A (zh) | 2015-07-29 |
| CA2889042A1 (fr) | 2014-05-22 |
| KR20150082588A (ko) | 2015-07-15 |
| EP2920158A1 (fr) | 2015-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69615025T2 (de) | Benzamid-derivate und deren verwendung als vasopressin-antagonisten | |
| DE69507293T2 (de) | Benzamid-derivate als vasopressin-antagonisten | |
| CA3035999C (fr) | Derives heterocycliques de benzene fusionne et composition pharmaceutique renfermant lesdits derives | |
| US5273989A (en) | 3,5-disubstituted 2-isoxazolines and isoxazoles, agents containing them and their use | |
| AU2021394226B2 (en) | Benzylamine or benzyl alcohol derivative and use thereof | |
| JP2000500481A (ja) | 新規ニューロキニンアンタゴニストとしての3―(4―置換―ピペリジニル―1)―1―(3,4―ジクロロフェニル)プロピルカーバメートおよび尿素および誘導体 | |
| AU2003220215A1 (en) | Nk1 antagonists | |
| TWI770841B (zh) | 作為組蛋白脫乙醯基酶6抑制劑之1,3,4-㗁二唑衍生物化合物及包含其的醫藥組合物 | |
| US20100197668A1 (en) | 1,2,3,4-TETRAHYDROPYRROLO[1,2-A]PYRAZINE-6-CARBOXAMIDE AND 2,3,4,5-TETRAHYDROPYRROLO[1,2-a][1,4]-DIAZEPINE-7-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF | |
| MX2011000588A (es) | Compuestos novedosos activos como antagonistas de receptor muscarinico. | |
| US9388166B2 (en) | 6-aminoindole derivatives as TRP channel antagonists | |
| US20100069328A1 (en) | Novel ortho-aminoanilides for the treatment of cancer | |
| AU2011336217B2 (en) | KAT II inhibitors | |
| HK1208028A1 (en) | Novel acetamide derivatives as trp channel antagonists | |
| KR20150068960A (ko) | 치환된 카바메이트 화합물 및 일시적 수용체 전위(trp) 채널 길항제로서의 이의 용도 | |
| GB2142021A (en) | 1 4-dihydropyridine derivatives their preparation and pharmaceutical compositions containing them | |
| HK1214244A1 (zh) | 咪唑并吡啶衍生物 | |
| US11155539B2 (en) | 4-pyridinylmethyl-morpholine derivatives and the use thereof as medicament | |
| WO1995025100A1 (fr) | Utilisation d'esters de l'acide 4-amino-5-chloro-2-methoxybenzoique comme 5-ht4 agonistes | |
| KR20050008664A (ko) | 모폴린 유도체 및 이의 중간체의 제조를 위한 방법 | |
| FR2717174A1 (fr) | Utilisation de pipéridinoéthyl esters de l'acide 4-amino-5-chloro-2-méthoxybenzoïque comme 5-HT4 agonistes. | |
| WO2010092286A1 (fr) | Derives de n-[(2-aza-bicyclo[2.1.1]hex-1-yl]-aryl-methyl]-benzamide, leur preparation et leur application en therapeutique |